Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion

South Africa News News

Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion
South Africa Latest News,South Africa Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 70 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 97%

Mirati develops commercial-stage oncology therapies, and through the deal, Bristol Myers Squibb will add lung-cancer medicine Krazati, among others, to its...

Bristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a deal valued at up to $5.8 billion.

The pharmaceutical giant announced it will pay $58 a share for Mirati, for a total equity value of $4.8 billion. Mirati stockholders will also receive one non-tradeable Contingent Value Right for each share they hold, potentially worth $12 a share in cash, representing an additional $1 billion of possible value.Mirati develops commercial-stage oncology therapies, and through the deal, Bristol Myers Squibb will add lung-cancer medicine Krazati, among others, to its portfolio.

“We are excited to add these assets to our portfolio and to accelerate their development as we seek to deliver more treatments for cancer patients,” Giovanni Caforio, Bristol Myers Squibb’s chief executive and chairman, said in a statement. “With a strong strategic fit, great science and clear value creation opportunities for our shareholders, the Mirati transaction is aligned with our business development goals.

The deal is expected to be dilutive to Bristol Myers Squibb’s non-GAAP earnings per share by about 35 cents a share in the first 12 months after the transaction closes. The merger is expected to close by the first half of 2024. Bristol Myers Squibb, with a market cap of about $118.4 billion, has seen its shares BMY, +0.43% sink 21% year to date. Mirati shares MRTX, -3.49% are up 33% this year. The S&P 500 SPX, in comparison, has gained about 12% in 2023.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionBristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionDeal expands pharmaceutical company’s portfolio of cancer drugs
Read more »

Bristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion deal
Read more »

Elyse Myers Is Sharing Her Postpartum Essentials, & It’s Honestly So HelpfulElyse Myers Is Sharing Her Postpartum Essentials, & It’s Honestly So HelpfulFrom adult diapers to a mini-fridge, Elyse Myers reveals the products she can't live without since giving birth to her second child.
Read more »

Lucrative Bristol Bay red king crab fishery to reopen after 2-year closureLucrative Bristol Bay red king crab fishery to reopen after 2-year closureThe Alaska Department of Fish and Game announced Friday morning that the lucrative crab fishery will open Oct. 15.
Read more »

Something went wrong. Please disable your blocker on Collider.Something went wrong. Please disable your blocker on Collider.Michael Myers and Pinhead could have teamed up to raise hell together!
Read more »

Connecticut woman Suzanne Laprise charged with starting shootout at Bristol police stationConnecticut woman Suzanne Laprise charged with starting shootout at Bristol police stationPolice in Connecticut said they arrested a woman Thursday who entered the Bristol police station and began opening fire on officers.
Read more »



Render Time: 2025-02-27 16:53:49